PRA focuses on late phase services
PRA has expanded its operations in the Netherlands and the UK in a bid to meet what it says is soaring client demand for late phase and product registration services.
Archives for May 30, 2012
Hospira asks FDA for critical drug list to cut shortages
Hospira has urged the FDA to create a list of critical drugs to limit the subjectivity of its draft guidance on drug shortages.
EXCLUSIVE
Home visits = regulatory thumbs up? ResearchNurses.co thinks so
The use of home visits in clinical trials could raise the chances of regulatory approval, according to ResearchNurses.co.
FDA alert drives cephalosporin sales drop at Aurobindo
A FDA import alert drove a double-digit drop in quarterly cephalosporin sales at Aurobindo and led to a one-third cut in full year earnings.
Covance inks alliances with Bayer and Eli Lilly
Covance has inked deals to provide preclinical services to Eli Lilly’s diabetes operations in China and late-stage support to Bayer Healthcare.
P-Gels mean cheaper and more varied drug development, says Patheon
Patheon says its new soft gel platform is creating cheaper development opportunities for drugsmakers.